Terms: = Colorectal cancer AND CASC5, AF15Q14, 57082, ENSG00000137812, D40, Q8NG31 AND Diagnosis
2 results:
1. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract] [Full Text] [Related]
2. Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer.
Hess LM; Zhu YE; Fang Y; Liepa AM
J Med Econ; 2021; 24(1):930-938. PubMed ID: 34289799
[TBL] [Abstract] [Full Text] [Related]
